Veltassa and Vesicare drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Veltassa (patiromer sorbitex calcium) and Vesicare (solifenacin succinate). Common drug interactions include hospitalisation among females and constipation among males.
The phase IV clinical study analyzes what interactions people have when they take Veltassa and Vesicare. It is created by eHealthMe based on reports of 45 people who take the same drugs from the FDA, and is updated regularly.
What is Veltassa?
Veltassa has active ingredients of patiromer sorbitex calcium. eHealthMe is studying from 15,649 Veltassa users. Check the latest studies of Veltassa.
What is Vesicare?
Vesicare has active ingredients of solifenacin succinate. It is often used in urge incontinence. eHealthMe is studying from 30,656 Vesicare users. Check the latest studies of Vesicare.
45 people who take Veltassa and Vesicare together, and have interactions are studied.
What are the common drug interactions of Veltassa and Vesicare, by gender? *:
female:
- Hospitalisation
- Constipation
- Diarrhoea
- Feeling cold
- Malaise (a feeling of general discomfort or uneasiness)
- Therapeutic response unexpected
- Urinary tract infection
- Blood magnesium decreased
- Joint swelling
- Nausea (feeling of having an urge to vomit)
male:
- Constipation
- Abdominal discomfort
- Fungal infection
- Hospitalisation
- Lung abscess (pus in lungs)
- Malaise (a feeling of general discomfort or uneasiness)
- Muscle spasms (muscle contraction)
- Oral discomfort (pain or irritation in mouth)
- Oral mucosal exfoliation (removal of mucous membrane of mouth)
- Papule
What are the common drug interactions of Veltassa and Vesicare, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
- Blood potassium decreased
- Fluid overload (too much fluid in the blood)
- Hospitalisation
- Infected fistula
60+:
- Constipation
- Abdominal discomfort
- Insomnia (sleeplessness)
- Abdominal pain upper
- Back pain
- Blood creatinine increased
- Blood sodium decreased
- Blood urea increased
- Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
- Chills (felling of cold)
What are the existing conditions these people have? *
- Hyperkalemia (damage to or disease of the kidney): 42 people, 93.33%
* Approximation only. Some reports may have incomplete information.
Do you take Veltassa and Vesicare?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Veltassa and Vesicare:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Veltassa:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Vesicare:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Veltassa and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Vesicare and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on patiromer sorbitex calcium and solifenacin succinate (the active ingredients of Veltassa and Vesicare, respectively), and Veltassa and Vesicare (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Bentyl vs. Mebeverine Hydrochloride, side effect and effectiveness comparison - 16 seconds ago
- Drug interactions of Furosemide and Quinine - 20 seconds ago
- Could Risperidone cause Heavy Or Prolong Menstrual Bleeding? - 21 seconds ago
- Could Avapro cause Respiratory Acidosis? - 22 seconds ago
- Cough Aggravated and Coronary Heart Disease - 39 seconds ago
- Metastatic Neoplasm and Dyspnea - 41 seconds ago
- Drug interactions of Clonazepam and Accutane - 49 seconds ago
- Drug interactions of Nalbuphine Hydrochloride and Methotrexate - 59 seconds ago
- Could Folic Acid cause Abnormal Loss Of Weight? - 59 seconds ago
- Could Skyrizi cause Seborrhea? - a minute ago